BioBuzz has partnered with WSGR to launch a brand new BioHealth Capital Region event series that will focus on highlighting our region’s strongest technology assets while bringing you insights from local CEO’s on the game-changing technologies they are bringing to market.
Join us for this first event of this series and hear from an all-star panel of CEOs from three of the hottest companies in immuno-oncology. Our speakers will discuss the promises and challenges they face as their companies bring new therapies to the bedside. I-O is the future of oncology and these CEOs are making their mark in the field, each with a different (sp) approach. We will dive deep with these four cutting-edge and diverse technologies to show how they are utilizing the immune system to combat cancer.
Jeff Galvin – Founder and CEO, AGT
Bill Hearl – Founder and CEO, ITI
Dr. Paul C. Tumeh – co-founder and CEO of BioGraph 55, Inc.
Moderator – Charles Andres, Phd, RAC – Associate at Wilson Sonsini Goodrich & Rosati
Visit our website: https://goo.gl/i6HKJ5
follow us at: